Last updated: 2026-10-14 16:27:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
DaVita Inc. (DVA) operates in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector and is listed on NYSE. The stock is currently priced at $181,29, with a market capitalisation of $11,60B and a P/E ratio of 13,71. Over the past 52 weeks, its price has ranged from $101,00 to $247,49. This page covers its latest market performance, valuation, price trends and company information.
$11,60B | |
$182,12 | |
$247,49 | |
$10,22 | |
$182,08 | |
117,14K | |
758,88K | |
13,71 | |
$247,49 | |
$101,00 | |
-- | |
-- |
DaVita Inc. (DVA) is currently trading at $181,29 as of 2026-10-14 16:25:00, down 0,44% ($0,80) from the previous close of $182,08
During today's regular trading session, DVA has traded between $10,22 and $247,49, with a trading volume of 117,14K shares. The current price is near the upper end of today's range.
Over the past seven days, DaVita Inc. (DVA) moved from $178,72 to $181,29, representing a gain of 1,44% ($2,56).
The stock traded between $175,41 and $185,93 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 487,97 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 54,8%
DVA is currently trading at $181,29, placing it 54,8% of the way from its 52-week low of $101,00 to its 52-week high of $247,49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
| Industry | SERVICES-MISC HEALTH & ALLIED SERVICES, NEC |
| Employees | 78000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of DaVita Inc. (DVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.